1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62F634147EB4D2D3E002588B800267892
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/2F634147EB4D2D3E002588B800267892?OpenDocument
18
19OpenDocument
2034.225.194.102
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Marketing Management » Marketing Strategy

Document Excerpt: Hybrid Work Models for Commercial Biopharma Organizations: Delivering Value and Benefits/Barriers

DB Image

Excerpt in Cart

ID: MD-834


Features:

9 Info Graphics

12 Data Graphics

180+ Metrics


Pages/Slides: 4


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5734 “Hybrid Work Models for Commercial Biopharma Organizations: Delivering Value and Benefits/Barriers”.

Industries Profiled:
Health Care; Biotech; Medical Device; Pharmaceutical; Consumer Products; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AccelRx; ADC Therapeutics; Aesculap; AstraZeneca; BELLUS Health; Boehringer Ingelheim; Cardinal Health; CSL Behring; DePuy Synthes; Janssen; Kaléo; Klosterfrau Healthcare Group; Novartis; Optum Specialty Pharmacy; Sanofi; Sanofi Genzyme; Servier; Sobi; Takeda Pharmaceuticals; Tris Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.